Short answer
Arcus Biosciences, Inc. (RCUS) filed an 8-K current report with the SEC on June 12, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All four Class II director nominees elected to serve until the 2029 annual meeting.
Arcus Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All four Class II director nominees elected to serve until the 2029 annual meeting
- Ernst & Young LLP appointment ratified for fiscal 2026, with 112,905,582 votes for
- Executive compensation approved on an advisory basis, with 94,920,421 votes for
- Director elections included 13,573,227 broker non-votes, limiting interpretation of shareholder support
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Arcus Biosciences, Inc. 8-K filings
Get the next RCUS 8-K as it lands
Follow RCUS for push alerts, or ask the research agent what this filing means.